BMO Capital Markets Upgrades Extendicare (TSE:EXE) to Outperform

Extendicare (TSE:EXE) was upgraded by research analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a note issued to investors on Thursday,BayStreet.CA reports. The brokerage presently has a C$24.00 price objective on the stock, up from their previous price objective of C$21.00. BMO Capital Markets’ target price points to a potential upside of 7.58% from the company’s previous close.

A number of other equities research analysts have also weighed in on EXE. Natl Bk Canada raised Extendicare to a “strong-buy” rating in a research note on Wednesday. CIBC boosted their price objective on Extendicare from C$18.00 to C$22.00 in a research report on Thursday, November 13th. TD Securities increased their price objective on Extendicare from C$15.00 to C$19.00 in a research note on Thursday, November 13th. Cibc World Mkts upgraded shares of Extendicare to a “strong-buy” rating in a report on Monday, September 22nd. Finally, Royal Bank Of Canada raised shares of Extendicare from a “sector perform” rating to an “outperform” rating and lifted their target price for the stock from C$15.00 to C$25.00 in a research note on Thursday. Three equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of C$23.86.

Extendicare Trading Up 6.3%

Extendicare stock traded up C$1.32 during mid-day trading on Thursday, hitting C$22.31. The company’s stock had a trading volume of 486,993 shares, compared to its average volume of 192,919. The business has a 50 day moving average price of C$16.98 and a 200-day moving average price of C$14.73. The company has a debt-to-equity ratio of 283.02, a current ratio of 0.62 and a quick ratio of 0.98. Extendicare has a 12 month low of C$9.69 and a 12 month high of C$22.57. The stock has a market cap of C$1.87 billion, a price-to-earnings ratio of 21.05 and a beta of 0.90.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.